Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07641335 · ClinicalTrials.gov registry record · NA
Effects of Caffeine on Chess Performance and Cognitive Function in Professional Chess Players
A NA study, sponsored by St. Louis University.
- Not yet
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT07641335 is a NA study that has not yet begun recruiting, run by St. Louis University. The registered enrollment target is 12 participants.
The verdict
NCT07641335, a NA study, has not yet begun recruiting, sponsored by St. Louis University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will examine whether caffeine improves cognitive and competitive performance in professional chess players during tournament-style games. In a randomized double-blind crossover design, participants will complete two experimental sessions in which they consume either caffeinated coffee or decaffeinated coffee before playing a standardized chess match. Cognitive performance will be assessed using attention and reaction-time tests, including the Stroop Test, Trail Making Test, and Puzzle Rush task. Chess performance outcomes such as move accuracy, time management, and error rates will also be evaluated. The study aims to determine whether moderate caffeine intake enhances focus, alertness, and decision-making during prolonged competitive chess play.
Interventions
- DIETARY_SUPPLEMENT Caffeinated Coffee
- DIETARY_SUPPLEMENT Decaffeinated Coffee Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07641335
The ClinicalTrials.gov registry entry for NCT07641335 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Caffeinated Coffee is the first listed.
NCT07641335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07641335 about?
NCT07641335 is a clinical study titled "Effects of Caffeine on Chess Performance and Cognitive Function in Professional Chess Players". This study will examine whether caffeine improves cognitive and competitive performance in professional chess players during tournament-style games. In a randomized double-blind crossover design, participants will complete two experimental sessions in which they consume either caffeinated coffee or ...
What is the current status of trial NCT07641335?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2026-06-15. Estimated completion is 2027-08.
What interventions are being tested in trial NCT07641335?
The interventions under investigation include: Caffeinated Coffee (DIETARY_SUPPLEMENT), Decaffeinated Coffee Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07641335?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.